Document Detail

Improving the clinical value of estimating glomerular filtration rate by reporting all values: a contrarian viewpoint.
MedLine Citation:
PMID:  20413994     Owner:  NLM     Status:  In-Process    
The serious limitations of the estimating glomerular filtration rate (eGFR) appear related not to a shortcoming of the equation, but to the futility of trying to force agreement between two inherently different parameters: a blood marker of kidney function with a very stable concentration (creatinine) and a renal filtration parameter that fluctuates continually (glomerular filtration rate, GFR). Although GFR is regarded as the ultimate determinant of kidney function, it may be less ideal as an early clinical marker to detect declining kidney function. Another shortcoming of GFR is that it has significant overlap between health and kidney disease states categorized according to stage I, II, etc. Serum creatinine has a real and measurable increase as kidney function declines, but this is often masked when creatinine is plotted on a scale of 1.0 mg/dl (88 micromol/l), which is well above the detection limit of modern creatinine methods of about 0.05 mg/dl. A new equation to estimate GFR, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation, modestly improves accuracy from 80.6% of the Modification of Diet in Renal Disease eGFRs being within 30% of the measured GFR, to 84.1% of the CKD-EPI eGFRs being within 30% of the measured GFR. Creatinine methods have recently been standardized to an isotope dilution mass stectrometry reference method. While this will lessen the systematic bias between methods, it will have no effect on either the imprecision of a particular creatinine method or on the inherent random differences between serum creatinine (or eGFR) and actual GFR. Finally, the eGFR is not recommended for reporting until it is well below a reference range for those with no kidney disease. However, if the eGFR were properly regarded as an age-, gender-, and race-adjusted serum creatinine, it could be reported at all values and become a more clinically useful parameter.
John G Toffaletti
Related Documents :
7859804 - The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabol...
24621104 - Benefits of sulfamethoxazole-trimethoprim prophylaxis on rates of sepsis after kidney t...
858804 - Warfarin elimination and responsiveness in patients with renal dysfunction.
23580474 - Nucleus pulposus cells expressing hbmp7 can prevent the degeneration of allogenic ivd i...
14500224 - Prediction of clinical response after renal angioplasty: respective value of renal dopp...
23294734 - Transplantation of human umbilical cord blood or amniotic epithelial stem cells allevia...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-04-23
Journal Detail:
Title:  Nephron. Clinical practice     Volume:  115     ISSN:  1660-2110     ISO Abbreviation:  Nephron Clin Pract     Publication Date:  2010  
Date Detail:
Created Date:  2010-07-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101159763     Medline TA:  Nephron Clin Pract     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  c177-81     Citation Subset:  IM    
Copyright Information:
Copyright 2010 S. Karger AG, Basel.
Clinical Laboratories and Department of Pathology, Duke University Medical Center, Durham, N.C. 27710, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is...
Next Document:  Intradialytic hypertension: it is time to act.